CIK 0000875320 · Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 043039129
- Phone
- 6173416393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,307,135
- in 1 filing, $6.3M under 10b5-1 plans
Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Kewalramani Reshma CEO & President | Sale 10b5-1 | −11,866 | $531.53 | $6.3M | 86,471 |
| 2026-10-20 | Brennan Daniel J. Director | Grant or award | +795 | $503.47 | $400K | 795 |
| 2026-10-15 | SACHS BRUCE I Director | Grant or award · Deferred Stock Units | +92.69 | $512.44 | $48K | 15,864.5 |
| 2026-10-15 | Garber Alan M Director | Grant or award · Deferred Stock Units | +29.27 | $512.44 | $15K | 94.73 |
| 2026-09-08 | van Grunsven Jasper EVP, CP and NPPO | Grant or award | +8,682 | 8,682 | ||
| 2026-08-28 | Ambrose Kristen SVP & Chief Accounting Officer | Grant or award | +5,000 | 11,624 | ||
| 2026-08-27 | SACHS BRUCE I Director | Gift | −6,000 | 39,000 | ||
| 2026-07-21 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Grant or award | +8,251 | 53,572 | ||
| 2026-07-21 | Sachdev Amit EVP Chief Patient & Ext Af Off | Grant or award | +8,251 | 66,512 | ||
| 2026-07-15 | SACHS BRUCE I Director | Grant or award · Deferred Stock Units | +99.94 | $475.28 | $47K | 15,771.81 |
| 2026-07-15 | Garber Alan M Director | Grant or award · Deferred Stock Units | +31.56 | $475.28 | $15K | 65.46 |
| 2026-07-02 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale 10b5-1 | −1,500 | $524.99 | $787K | 45,321 |
| 2026-07-02 | McKechnie Duncan EVP, Chief Commercial Officer | Sale 10b5-1 | −1,541 | $519.00 | $800K | 11,001 |
| 2026-07-01 | Liu Joy EVP and Chief Legal Officer | Sale 10b5-1 | −828 | $502.71 | $416K | 19,131 |
| 2026-06-26 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −596 | $482.50 | $288K | 15,337 |
| 2026-06-18 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −1,020 | $462.17 | $471K | 15,933 |
| 2026-06-15 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −4,062 | $450.00 | $1.8M | 16,953 |
| 2026-06-05 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −1,745 | $450.00 | $785K | 21,015 |
| 2026-06-01 | Liu Joy EVP and Chief Legal Officer | Sale 10b5-1 | −828 | $439.91 | $364K | 19,959 |
| 2026-05-29 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −1,974 | $450.00 | $888K | 22,760 |
Page 1 of 10 · 182 trades